脑脊液代谢组学分析揭示急性淋巴细胞白血病中枢神经系统受累的早期诊断模型
该研究对急性淋巴细胞白血病(ALL)患者进行脑脊液非靶向代谢组学分析,识别出33种在伴或不伴中枢神经系统受累(CNSI)患者间显著改变的代谢物,并基于8-羟基鸟苷、L-苯丙氨酸和次黄嘌呤三个独立风险因素构建CNSI评估评分(CES)。该模型在训练集和验证集中的阳性预测值分别为95.9%和85.6%,且CES评分随CNSI受累程度升高而增加,可用于预测CNSI进展并构建列线图。
要点
- 基于脑脊液代谢组学识别出33种与ALL中枢神经系统受累相关的显著改变代谢物。
- 由8-羟基鸟苷、L-苯丙氨酸和次黄嘌呤构建的CES模型在训练集和验证集中阳性预测值分别为95.9%和85.6%。
- CES评分随CNSI受累程度升高而增加,并能预测CNSI进展,已构建临床列线图。
核心结论
- 该脑脊液代谢组学研究可能有助于理解CNSI的发病机制、早期诊断CNSI并最终实现个性化精准治疗。
研究设计与样本
- 对急性淋巴细胞白血病患者进行脑脊液非靶向代谢组学分析,以识别可早期诊断CNSI的独立风险生物标志物。
主要发现
- 在伴与不伴CNSI的ALL患者之间识别出33种显著改变的代谢物。
- 基于8-羟基鸟苷、L-苯丙氨酸和次黄嘌呤三个独立风险因素构建CNSI评估评分(CES)。
- CES模型在训练集和验证集中的阳性预测值分别为95.9%和85.6%。
- CES评分随CNSI受累程度升高而增加。
- 通过追踪CNSI不同阶段(CNSI前、CNSI期间和CNSI后缓解期)的CES变化验证了该模型,CES显示出良好的预测CNSI进展的能力。
临床怎么用
- 作者指出该研究可能有助于理解CNSI发病机制、早期诊断CNSI并最终实现个性化精准治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The pathogenesis of central nervous system involvement (CNSI) in patients with acute lymphoblastic leukaemia (ALL) remains unclear and a robust biomarker of early diagnosis is missing. An untargeted cerebrospinal fluid (CSF) metabolomics analysis was performed to identify independent risk biomarkers that could diagnose CNSI at the early stage. Thirty-three significantly altered metabolites between ALL patients with and without CNSI were identified, and a CNSI evaluation score (CES) was constructed to predict the risk of CNSI based on three independent risk factors (8-hydroxyguanosine, l-phenylalanine and hypoxanthine). This predictive model could diagnose CNSI with positive prediction values of 95.9% and 85.6% in the training and validation sets respectively. Moreover, CES score increased with the elevated level of central nervous system (CNSI) involvement. In addition, we validated this model by tracking the changes in CES at different stages of CNSI, including before CNSI and during CNSI, and in remission after CNSI. The CES showed good ability to predict the progress of CNSI. Finally, we constructed a nomogram to predict the risk of CNSI in clinical practice, which performed well compared with observed probability. This unique CSF metabolomics study may help us understand the pathogenesis of CNSI, diagnose CNSI at the early stage, and sequentially achieve personalized precision treatment.
引用
- Song Z, Tang G, Zhuang C, et al. Metabolomic profiling of cerebrospinal fluid reveals an early diagnostic model for central nervous system involvement in acute lymphoblastic leukaemia. Br J Haematol. 2022. PMID: 35708546. doi:10.1111/bjh.18307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。